Longer colonoscopy withdrawal times associated with lower cancer rate
the ONA take:
Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates, according to research by a Veterans Affairs team.
The link between colonoscopy withdrawal time and patient outcomes is already known; this study provides strong evidence to support clinical guidelines regarding colonoscopy withdrawal times. Current guidelines recommend a withdrawal time of 6 minutes or more.
In this study, data on colonoscopies performed over 6 years by 51 gastroenterologists in a large community practice were evaluated. The average withdrawal time for the practice was 8.6 minutes; however, approximately 10% of the doctors had individual averages of less than 6 minutes.
The researchers then reviewed the state’s cancer registry for colorectal cancer cases among patients who had been screened at the practice during the study period, including cancers that occurred within 5 years of the last screening.
Referred to as interval cancers, these cancers are assumed to have developed from polyps that were either not detected during the colonoscopy, or not fully removed.
The American College of Gastroenterology acknowledges that some colons can be effectively examined in less than 6 minutes, but these findings show longer colonoscopy withdrawal times correlate with lower risk for interval cancer. The researchers report that further research is needed on quality measures for this screening procedure.
Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|